Alentis Therapeutics welcomes Dr. William Pao to its Board as Independent Director
– SWITZERLAND, Basel – Alentis Therapeutics, a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, today announced the appointment of Dr.…